No Data
No Data
Exxon Mobil Unusual Options Activity For October 15
Nasdaq Down 150 Points; Johnson & Johnson Reports Better-Than-Expected Q3 Results
JNJ Releases Positive Data on Nipocalimab for Myasthenia Gravis in Adolescents
Google Goes Nuclear For AI Power, Israeli Restraint Impacts Stocks, Gold, And Oil
McDonald's To Rally Around 13%? Here Are 10 Top Analyst Forecasts For Tuesday
'Merck Keeps Kinase Inhibitor Options Open As It Partners With Exelixis To Test Zanzalintinib Alongside Welireg In Renal Cancer; Collaboration Raises Questions About Merck's Ongoing Renal Trials With Lenvima, Litespark-011 Trial Completion Is Delayed...
102159783 : why schd still drop while another ef up